When a biological drug patent expires, alternative biosimilar products are developed. The development of biosimilar products is complicated and involves numerous considerations and steps. The assessment of biosimilarity and interchangeability is also complicated and difficult. Biosimilar Drug Product Development presents current issues for the development of biosimilars and gives detailed reviews of its various stages and contributing factors as well as relevant regulatory pathways and pre- and post-approval issues.
Cumpărați această carte electronică și primiți încă 1 GRATUIT!
Format EPUB ● Pagini 496 ● ISBN 9781351646185 ● Editor Shein-Chung Chow & . Paul Declerck ● Editura CRC Press ● Publicat 2017 ● Descărcabil 3 ori ● Valută EUR ● ID 8116104 ● Protecție împotriva copiilor Adobe DRM
Necesită un cititor de ebook capabil de DRM